Where does AngioDynamics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AngioDynamics, Inc. ranks #2,636 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AngioDynamics, Inc. hold?

AngioDynamics, Inc. holds 147 US utility patents granted between 2015 and 2025, spanning 16 technology areas.

What is AngioDynamics, Inc.'s Innovation Score?

AngioDynamics, Inc. has an Innovation Score of 43.5 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does AngioDynamics, Inc. focus on?

AngioDynamics, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 84 patents, ranking #213 of 7,127 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is AngioDynamics, Inc.'s patent grant rate increasing or decreasing?

AngioDynamics, Inc.'s recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for AngioDynamics, Inc.'s patents?

AngioDynamics, Inc.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AngioDynamics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

AngioDynamics, Inc.

USPTO PatentsView assignee record - 147 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Angiodynamics ranks #2,636 of 49,997 tracked US assignees by granted-patent volume, with 147 patents across 16 technology areas.

#2,636
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.5/100): 14.3
avg claims per patent: -43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2636 · US Corporation #2,636 · 147 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 147 grants
TOP-DECILE #2,636/49,997
PHOTO-FINISH Aircelle
CPC-FOCUS A61B · 16 areas
INNOV-PAR 43.5/100
CLAIMS-RICH 14.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aircelle (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Angiodynamics’s 43.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 17.3 pts (40%) Velocity 3.5 pts (8%) Breadth 14.1 pts (32%) Claim depth 8.6 pts (20%)

Qualcomm Incorporated · highest

85
AngioDynamics · this assignee

43
AZ Materials… · near

43
Bromine Compounds · near

43
The AES · near

43
UEA Enterprises · near

43
3D Lighting… · lowest

7

What this shows Angiodynamics's Innovation Score is 43.5/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Angiodynamics?

Each dot is one of Angiodynamics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Angiodynamics’s own 14.3 claims/patent is at or below the 15.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Angiodynamics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Angiodynamics's grants concentrate

AngioDynamics, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 57.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (21 grants) versus a trough of 5 in 2022. By volume, Angiodynamics sits between Ocient Holdings LLC and Hitachi Vantara, Ltd..

Angiodynamics's three-year grant acceleration

From 2019–2021 to 2022–2024, AngioDynamics, Inc. moved from 44 to 23 grants (0.52x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,634. See the growth leaderboard.

Ocient Holdings

148
The University Of…

148
ZF Automotive Ger…

148
Aircelle

147
Blue Yonder Group

147
Cleversafe

147
Giesecke+Devrient…

147
Hitachi Vantara

147
Angiodynamics ◀

147

What this shows AngioDynamics holds 147 patents at rank #2,636, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AngioDynamics

By rank, the assignees closest to #2,636 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in AngioDynamics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for AngioDynamics, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), AngioDynamics ranks #213 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

AZ Electronic Materials (Luxembourg) S.A.R.L. 43 Bromine Compounds Ltd. 43 The AES Corporation 43 UEA Enterprises Ltd 43

Similar claim depth

Nearest assignees by average claims per patent (14.3 here).

CPS Technology Holdings LLC 14.3 avg Qatar Foundation FOR Education, Science AND Community Development 14.3 avg Nuctech Company Limited 14.3 avg Sterlite Technologies Limited 14.3 avg

Angiodynamics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

AngioDynamics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	18	12.2%
2016	16	10.9%
2017	15	10.2%
2018	21	14.3%
2019	17	11.6%
2020	19	12.9%
2021	8	5.4%
2022	5	3.4%
2023	8	5.4%
2024	10	6.8%
2025partial year	10	6.8%

Which technologies does AngioDynamics, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 84

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 66

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 22

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 9

Y10T - Technical Subjects Covered BY Former US Classification 7

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

C08L - Compositions OF Macromolecular Compounds 4

G02B - Optical Elements, Systems OR Apparatus 3

G01T - Measurement OF Nuclear OR X-radiation 3

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 2

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

G06T - Image Data Processing OR Generation, IN General 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AngioDynamics, Inc.'s patent record in context - here's where to go next.

AngioDynamics, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 57.1% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #2,636 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AngioDynamics, Inc. against Ocient Holdings LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.